Literature DB >> 16491288

Dissimilar PTH, gastrin, and calcitonin responses to oral calcium and peptones in hypocalciuric hypercalcemia, primary hyperparathyroidism, and normal subjects: a useful tool for differential diagnosis.

Maurizio Bevilacqua1, Ligia J Dominguez, Velella Righini, Valeria Valdes, Tarcisio Vago, Ennio Leopaldi, Gabriella Baldi, Massimo Barrella, Mario Barbagallo.   

Abstract

UNLABELLED: We analyzed gastrin, PTH, and calcitonin responses to oral calcium and peptones in hypocalciuric hypercalcemia, mild primary hyperparathyroidism, and normal controls. We observed diverse hormonal responses that may help in the differential diagnosis of these conditions.
INTRODUCTION: Hypocalciuric hypercalcemia (HH) is consequent to calcium-sensing receptor (CaSR) genetic mutations or anti-CaSR antibodies. CaSR is expressed in parathyroid tissue, thyroid C cells, and gastrin-secreting cells, where it has been suggested that on calcium and/or amino acid allosteric activation, promotes gastrin secretion.
MATERIALS AND METHODS: We evaluated gastrin, PTH, and calcitonin responses to oral calcium (1 g) and peptones (10 g) in 10 patients with HH (mean age, 58.5 +/- 10.3 years; F/M = 9/1), 15 patients with primary hyperparathyroidism (PH; mean age, 60.4 +/- 8.3 years; F/M = 11/4), and 30 healthy controls (mean age, 60.3 +/- 8.1 years). Statistical analyses for differences during oral loading tests were calculated with ANOVA for repeated measurements and comparisons between two groups were performed with Student's t-test.
RESULTS: PTH response to peptones was markedly increased in patients with PH compared with flat responses in controls and HH patients (p < 0.05). Gastrin increase after oral calcium was absent in HH and PH subjects (p < 0.05 versus controls), and gastrin responses to peptones were blunted in HH and PH subjects compared with controls (p < 0.05). PTH drop and calcitonin increase after calcium load observed in controls were absent in HH and PH subjects (p < 0.05).
CONCLUSIONS: The marked difference in PTH response elicited by peptones observed in PH compared with subjects with HH may help in the differential diagnosis of these conditions without genetic studies. Peptones may stimulate CaSR-controlled hormones as an allosteric regulatory pathway. CaSR abnormalities may help to explain the different calcium- and peptones-induced hormonal responses observed in PH and HH compared with normal subjects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16491288     DOI: 10.1359/JBMR.051210

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  6 in total

1.  Calcium-sensing receptor is a physiologic multimodal chemosensor regulating gastric G-cell growth and gastrin secretion.

Authors:  Jianying Feng; Clark D Petersen; David H Coy; Jian-Kang Jiang; Craig J Thomas; Martin R Pollak; Stephen A Wank
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

Review 2.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

Review 3.  Calcitonin: current concepts and differential diagnosis.

Authors:  Andreas Kiriakopoulos; Periklis Giannakis; Evangelos Menenakos
Journal:  Ther Adv Endocrinol Metab       Date:  2022-05-21       Impact factor: 4.435

4.  Parathyroid hormone and calcitonin response during the calcium infusion test in patients with primary hyperparathyroidism.

Authors:  Emir Muzurović; Karin Zibar Tomšić; Snežana Vujošević; Milan Petakov
Journal:  Hormones (Athens)       Date:  2022-02-01       Impact factor: 2.885

5.  Diagnostic accuracy of routine calcitonin measurement for the detection of medullary thyroid carcinoma in the management of patients with nodular thyroid disease: a meta-analysis.

Authors:  Irfan Vardarli; Manuel Weber; Frank Weidemann; Dagmar Führer; Ken Herrmann; Rainer Görges
Journal:  Endocr Connect       Date:  2021-03       Impact factor: 3.335

6.  Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer

Authors:  Emine Kartal Baykan; Mehmet Erdoğan
Journal:  Turk J Med Sci       Date:  2021-04-30       Impact factor: 0.973

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.